Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression

Porcine circovirus type 2 (PCV2) infections cause important respiratory diseases in the pig industry and are associated with many bacterial, mycoplasmal, and viral complications. In this study, a heterologous PCV2 major capsid protein (MCP) was expressed in the Bordetella bronchiseptica aroA mutant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Veterinary microbiology 2009-09, Vol.138 (3), p.318-324
Hauptverfasser: Kim, Taejung, Toan, Nguyen Tat, Seo, Jayoung, Jung, Bockgie, Lee, Jaeil, Lee, Bongjoo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 324
container_issue 3
container_start_page 318
container_title Veterinary microbiology
container_volume 138
creator Kim, Taejung
Toan, Nguyen Tat
Seo, Jayoung
Jung, Bockgie
Lee, Jaeil
Lee, Bongjoo
description Porcine circovirus type 2 (PCV2) infections cause important respiratory diseases in the pig industry and are associated with many bacterial, mycoplasmal, and viral complications. In this study, a heterologous PCV2 major capsid protein (MCP) was expressed in the Bordetella bronchiseptica aroA mutant strain (BBS-MCP) and used as a live vaccine vehicle. Mice and pigs were immunized with live BBS-MCP via the intranasal route. The antibodies against MCP were induced successfully in the serum as determined by ELISA. In the PCV2 challenge experiment, viral DNA was removed successfully from the lymph nodes of pigs vaccinated with live BBS-MCP. Overall, BBS-MCP is believed to be a good candidate for the development of a live-attenuated vaccine against PCV2 infections.
doi_str_mv 10.1016/j.vetmic.2009.04.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734040714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378113509002053</els_id><sourcerecordid>734040714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-fa8b01c581cba02db01d1650cd95af913a62639cc8c5a4e2dd7667cd0db219623</originalsourceid><addsrcrecordid>eNp90c1u1DAQAOAIgehSeAMEvlBOu4wd5--CVCr-pEocoGdrMp50vUriYGdX9BV46nqbFdx68cjW5_GMJ8teS9hIkOWH3ebA8-BoowCaDegNSP0kW8m6yteq0OpptoK8qtdS5sVZ9iLGHQDopoTn2ZlstKrTssr-fvLB8sx9j6INfqStizzNjlBg8Jdi2M84zgKjQNG7A4sDErkxRd466ll0PohtShB872_9PorJhwdALpA_uJCO5ruJhRID7hImnKKzYgp-ZjcK_jMFjtH58WX2rMM-8qtTPM9uvnz-dfVtff3j6_ery-s1aV3O6w7rFiQVtaQWQdm0sbIsgGxTYNfIHEtV5g1RTQVqVtZWZVmRBdsq2ZQqP8_eL3lTCb_3HGczuEjHHxg5NWCqXIOGSuokLx6VCupcKZ0nqBdIwccYuDNTcAOGOyPBHKdldmaZljlOy4A28JD_zSn_vh3Y_r90Gk8C704AI2HfBRzJxX8u9VPpShbJvV1ch97gbUjm5qcCmaena5AASXxcBKefPTgOJpLjkdi6wDQb693jtd4DHQbA1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20832243</pqid></control><display><type>article</type><title>Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kim, Taejung ; Toan, Nguyen Tat ; Seo, Jayoung ; Jung, Bockgie ; Lee, Jaeil ; Lee, Bongjoo</creator><creatorcontrib>Kim, Taejung ; Toan, Nguyen Tat ; Seo, Jayoung ; Jung, Bockgie ; Lee, Jaeil ; Lee, Bongjoo</creatorcontrib><description>Porcine circovirus type 2 (PCV2) infections cause important respiratory diseases in the pig industry and are associated with many bacterial, mycoplasmal, and viral complications. In this study, a heterologous PCV2 major capsid protein (MCP) was expressed in the Bordetella bronchiseptica aroA mutant strain (BBS-MCP) and used as a live vaccine vehicle. Mice and pigs were immunized with live BBS-MCP via the intranasal route. The antibodies against MCP were induced successfully in the serum as determined by ELISA. In the PCV2 challenge experiment, viral DNA was removed successfully from the lymph nodes of pigs vaccinated with live BBS-MCP. Overall, BBS-MCP is believed to be a good candidate for the development of a live-attenuated vaccine against PCV2 infections.</description><identifier>ISSN: 0378-1135</identifier><identifier>EISSN: 1873-2542</identifier><identifier>DOI: 10.1016/j.vetmic.2009.04.014</identifier><identifier>PMID: 19428194</identifier><identifier>CODEN: VMICDQ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Administration, Intranasal ; Animals ; antibody formation ; Applied microbiology ; Bacteriology ; Biological and medical sciences ; Bordetella bronchiseptica ; Bordetella bronchiseptica - genetics ; Capsid Proteins - immunology ; Circovirus - immunology ; Cloning, Molecular ; coat proteins ; disease prevention ; Fundamental and applied biological sciences. Psychology ; gene expression ; Gene Expression Regulation, Bacterial ; Heterologous antigen expression vehicle ; immune response ; intranasal administration ; live vaccines ; lymph nodes ; Mice ; Microbiology ; Miscellaneous ; mutants ; Mutation ; Porcine circovirus ; Porcine circovirus type 2 ; Porcine Postweaning Multisystemic Wasting Syndrome - prevention &amp; control ; Porcine Postweaning Multisystemic Wasting Syndrome - virology ; postweaning multisystemic wasting syndrome ; protective effect ; recombinant vaccines ; Swine ; swine diseases ; vaccination ; vaccine development ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; vector vaccines ; viral antigens ; Viral Proteins - genetics ; Viral Proteins - immunology ; Viral Vaccines - administration &amp; dosage ; Viral Vaccines - immunology ; Virology</subject><ispartof>Veterinary microbiology, 2009-09, Vol.138 (3), p.318-324</ispartof><rights>2009 Elsevier B.V.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-fa8b01c581cba02db01d1650cd95af913a62639cc8c5a4e2dd7667cd0db219623</citedby><cites>FETCH-LOGICAL-c446t-fa8b01c581cba02db01d1650cd95af913a62639cc8c5a4e2dd7667cd0db219623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.vetmic.2009.04.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21974715$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19428194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Taejung</creatorcontrib><creatorcontrib>Toan, Nguyen Tat</creatorcontrib><creatorcontrib>Seo, Jayoung</creatorcontrib><creatorcontrib>Jung, Bockgie</creatorcontrib><creatorcontrib>Lee, Jaeil</creatorcontrib><creatorcontrib>Lee, Bongjoo</creatorcontrib><title>Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression</title><title>Veterinary microbiology</title><addtitle>Vet Microbiol</addtitle><description>Porcine circovirus type 2 (PCV2) infections cause important respiratory diseases in the pig industry and are associated with many bacterial, mycoplasmal, and viral complications. In this study, a heterologous PCV2 major capsid protein (MCP) was expressed in the Bordetella bronchiseptica aroA mutant strain (BBS-MCP) and used as a live vaccine vehicle. Mice and pigs were immunized with live BBS-MCP via the intranasal route. The antibodies against MCP were induced successfully in the serum as determined by ELISA. In the PCV2 challenge experiment, viral DNA was removed successfully from the lymph nodes of pigs vaccinated with live BBS-MCP. Overall, BBS-MCP is believed to be a good candidate for the development of a live-attenuated vaccine against PCV2 infections.</description><subject>Administration, Intranasal</subject><subject>Animals</subject><subject>antibody formation</subject><subject>Applied microbiology</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Bordetella bronchiseptica</subject><subject>Bordetella bronchiseptica - genetics</subject><subject>Capsid Proteins - immunology</subject><subject>Circovirus - immunology</subject><subject>Cloning, Molecular</subject><subject>coat proteins</subject><subject>disease prevention</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>gene expression</subject><subject>Gene Expression Regulation, Bacterial</subject><subject>Heterologous antigen expression vehicle</subject><subject>immune response</subject><subject>intranasal administration</subject><subject>live vaccines</subject><subject>lymph nodes</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>mutants</subject><subject>Mutation</subject><subject>Porcine circovirus</subject><subject>Porcine circovirus type 2</subject><subject>Porcine Postweaning Multisystemic Wasting Syndrome - prevention &amp; control</subject><subject>Porcine Postweaning Multisystemic Wasting Syndrome - virology</subject><subject>postweaning multisystemic wasting syndrome</subject><subject>protective effect</subject><subject>recombinant vaccines</subject><subject>Swine</subject><subject>swine diseases</subject><subject>vaccination</subject><subject>vaccine development</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>vector vaccines</subject><subject>viral antigens</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - immunology</subject><subject>Viral Vaccines - administration &amp; dosage</subject><subject>Viral Vaccines - immunology</subject><subject>Virology</subject><issn>0378-1135</issn><issn>1873-2542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90c1u1DAQAOAIgehSeAMEvlBOu4wd5--CVCr-pEocoGdrMp50vUriYGdX9BV46nqbFdx68cjW5_GMJ8teS9hIkOWH3ebA8-BoowCaDegNSP0kW8m6yteq0OpptoK8qtdS5sVZ9iLGHQDopoTn2ZlstKrTssr-fvLB8sx9j6INfqStizzNjlBg8Jdi2M84zgKjQNG7A4sDErkxRd466ll0PohtShB872_9PorJhwdALpA_uJCO5ruJhRID7hImnKKzYgp-ZjcK_jMFjtH58WX2rMM-8qtTPM9uvnz-dfVtff3j6_ery-s1aV3O6w7rFiQVtaQWQdm0sbIsgGxTYNfIHEtV5g1RTQVqVtZWZVmRBdsq2ZQqP8_eL3lTCb_3HGczuEjHHxg5NWCqXIOGSuokLx6VCupcKZ0nqBdIwccYuDNTcAOGOyPBHKdldmaZljlOy4A28JD_zSn_vh3Y_r90Gk8C704AI2HfBRzJxX8u9VPpShbJvV1ch97gbUjm5qcCmaena5AASXxcBKefPTgOJpLjkdi6wDQb693jtd4DHQbA1Q</recordid><startdate>20090918</startdate><enddate>20090918</enddate><creator>Kim, Taejung</creator><creator>Toan, Nguyen Tat</creator><creator>Seo, Jayoung</creator><creator>Jung, Bockgie</creator><creator>Lee, Jaeil</creator><creator>Lee, Bongjoo</creator><general>Elsevier B.V</general><general>Amsterdam; New York: Elsevier</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20090918</creationdate><title>Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression</title><author>Kim, Taejung ; Toan, Nguyen Tat ; Seo, Jayoung ; Jung, Bockgie ; Lee, Jaeil ; Lee, Bongjoo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-fa8b01c581cba02db01d1650cd95af913a62639cc8c5a4e2dd7667cd0db219623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Administration, Intranasal</topic><topic>Animals</topic><topic>antibody formation</topic><topic>Applied microbiology</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Bordetella bronchiseptica</topic><topic>Bordetella bronchiseptica - genetics</topic><topic>Capsid Proteins - immunology</topic><topic>Circovirus - immunology</topic><topic>Cloning, Molecular</topic><topic>coat proteins</topic><topic>disease prevention</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>gene expression</topic><topic>Gene Expression Regulation, Bacterial</topic><topic>Heterologous antigen expression vehicle</topic><topic>immune response</topic><topic>intranasal administration</topic><topic>live vaccines</topic><topic>lymph nodes</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>mutants</topic><topic>Mutation</topic><topic>Porcine circovirus</topic><topic>Porcine circovirus type 2</topic><topic>Porcine Postweaning Multisystemic Wasting Syndrome - prevention &amp; control</topic><topic>Porcine Postweaning Multisystemic Wasting Syndrome - virology</topic><topic>postweaning multisystemic wasting syndrome</topic><topic>protective effect</topic><topic>recombinant vaccines</topic><topic>Swine</topic><topic>swine diseases</topic><topic>vaccination</topic><topic>vaccine development</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>vector vaccines</topic><topic>viral antigens</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - immunology</topic><topic>Viral Vaccines - administration &amp; dosage</topic><topic>Viral Vaccines - immunology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Taejung</creatorcontrib><creatorcontrib>Toan, Nguyen Tat</creatorcontrib><creatorcontrib>Seo, Jayoung</creatorcontrib><creatorcontrib>Jung, Bockgie</creatorcontrib><creatorcontrib>Lee, Jaeil</creatorcontrib><creatorcontrib>Lee, Bongjoo</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Taejung</au><au>Toan, Nguyen Tat</au><au>Seo, Jayoung</au><au>Jung, Bockgie</au><au>Lee, Jaeil</au><au>Lee, Bongjoo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression</atitle><jtitle>Veterinary microbiology</jtitle><addtitle>Vet Microbiol</addtitle><date>2009-09-18</date><risdate>2009</risdate><volume>138</volume><issue>3</issue><spage>318</spage><epage>324</epage><pages>318-324</pages><issn>0378-1135</issn><eissn>1873-2542</eissn><coden>VMICDQ</coden><abstract>Porcine circovirus type 2 (PCV2) infections cause important respiratory diseases in the pig industry and are associated with many bacterial, mycoplasmal, and viral complications. In this study, a heterologous PCV2 major capsid protein (MCP) was expressed in the Bordetella bronchiseptica aroA mutant strain (BBS-MCP) and used as a live vaccine vehicle. Mice and pigs were immunized with live BBS-MCP via the intranasal route. The antibodies against MCP were induced successfully in the serum as determined by ELISA. In the PCV2 challenge experiment, viral DNA was removed successfully from the lymph nodes of pigs vaccinated with live BBS-MCP. Overall, BBS-MCP is believed to be a good candidate for the development of a live-attenuated vaccine against PCV2 infections.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19428194</pmid><doi>10.1016/j.vetmic.2009.04.014</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-1135
ispartof Veterinary microbiology, 2009-09, Vol.138 (3), p.318-324
issn 0378-1135
1873-2542
language eng
recordid cdi_proquest_miscellaneous_734040714
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Intranasal
Animals
antibody formation
Applied microbiology
Bacteriology
Biological and medical sciences
Bordetella bronchiseptica
Bordetella bronchiseptica - genetics
Capsid Proteins - immunology
Circovirus - immunology
Cloning, Molecular
coat proteins
disease prevention
Fundamental and applied biological sciences. Psychology
gene expression
Gene Expression Regulation, Bacterial
Heterologous antigen expression vehicle
immune response
intranasal administration
live vaccines
lymph nodes
Mice
Microbiology
Miscellaneous
mutants
Mutation
Porcine circovirus
Porcine circovirus type 2
Porcine Postweaning Multisystemic Wasting Syndrome - prevention & control
Porcine Postweaning Multisystemic Wasting Syndrome - virology
postweaning multisystemic wasting syndrome
protective effect
recombinant vaccines
Swine
swine diseases
vaccination
vaccine development
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
vector vaccines
viral antigens
Viral Proteins - genetics
Viral Proteins - immunology
Viral Vaccines - administration & dosage
Viral Vaccines - immunology
Virology
title Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T04%3A31%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bordetella%20bronchiseptica%20aroA%20mutant%20as%20a%20live%20vaccine%20vehicle%20for%20heterologous%20porcine%20circovirus%20type%202%20major%20capsid%20protein%20expression&rft.jtitle=Veterinary%20microbiology&rft.au=Kim,%20Taejung&rft.date=2009-09-18&rft.volume=138&rft.issue=3&rft.spage=318&rft.epage=324&rft.pages=318-324&rft.issn=0378-1135&rft.eissn=1873-2542&rft.coden=VMICDQ&rft_id=info:doi/10.1016/j.vetmic.2009.04.014&rft_dat=%3Cproquest_cross%3E734040714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20832243&rft_id=info:pmid/19428194&rft_els_id=S0378113509002053&rfr_iscdi=true